ANA (Antinuclear Antibodies)
Screens for autoantibodies directed against components of the cell nucleus — the standard first-line test for systemic autoimmune disease.
Useful when there's persistent unexplained inflammation, joint pain, rashes, or profound fatigue. Important caveat: a positive ANA alone doesn't mean disease.
Read those two numbers together and the whole problem is visible. A titre chosen to be 98% sensitive for lupus is positive in more than one in ten healthy people, so in anyone without symptoms a positive ANA is far more likely to be noise than disease. That is not a reason to ignore a positive — it is the reason the test belongs downstream of a clinical question rather than on a wellness panel. The titre and the pattern are separate pieces of information and a report that gives only 'positive' is incomplete.
What did your ANA report say?
What to do next. ANA is a screening test, not a diagnosis, and a positive result alone diagnoses nothing. The next step is specific antibody testing guided by symptoms and pattern. Do not start immune-modulating supplements on an ANA alone — and note that in autoimmunity the immune-STIMULATING category (echinacea, astragalus, beta-glucans) is the wrong class; the modulating ones are the sensible side.
What ANA (Antinuclear Antibodies) actually measures — the analyte, and the assay
The reference method is a photograph, read by a person. Serum is diluted, laid over HEp-2 cells fixed to a slide, and any antibody that binds a nuclear antigen is revealed with a fluorescein-labeled anti-human IgG. A technologist then reports two things: the highest dilution at which fluorescence is still visible, and the pattern of that fluorescence. Neither is a concentration.
Titer is a dilution series, so it moves in doubling steps. 1:80, 1:160, 1:320. A change from 1:160 to 1:320 is one tube, which is within the reproducibility of the method — it is not a doubling of anything in the patient.
Solid-phase ANA screens are a different test with the same name. An ELISA or multiplex bead assay coated with a selected panel of nuclear antigens will miss antibodies against antigens not on the panel and will call some patterns that immunofluorescence would not. Which method produced a result changes what a negative means Pisetsky 2017.
The pattern carries real information and is often discarded. Homogeneous, speckled, nucleolar, centromere and dense fine speckled each point at different antigen families — and the dense fine speckled pattern is not always DFS70, which is why the pattern needs confirming with a specific antibody test rather than being read off the slide Sanchez-Hernandez 2023.
ANA (Antinuclear Antibodies): what changes the blood, and what only changes the reading
What changes the antibodies in you:
- Having an autoimmune rheumatic disease, which is what the test is for — and it is very good at ruling one out.
- Age and sex. Prevalence of antinuclear autoantibodies rises with age and is higher in women; analysis of a Polish population quantified both effects Krzemien 2022.
- Simply being healthy. A substantial share of people with no disease carry a positive ANA, and the review making that point is titled around it: autoimmunity is not a synonym of autoimmune disease Pashnina 2021.
- Infection, particularly viral, which produces transient positivity.
- Drugs — hydralazine, procainamide, minocycline, TNF inhibitors — which induce antibodies that usually recede after withdrawal.
- Malignancy, chronic liver disease and thyroid autoimmunity, each associated with positivity in the absence of lupus.
What changes only the reading:
- The starting dilution. A laboratory screening at 1:40 reports far more positives than one screening at 1:160, and the difference is policy rather than biology Volkmann 2012.
- Which method. Immunofluorescence and solid-phase screens disagree in both directions Pisetsky 2017.
- Which technologist. Pattern assignment and endpoint titer are read visually, and reader variation is a documented source of disagreement Sanchez-Hernandez 2023.
- The HEp-2 substrate lot and the microscope's light source, which shift where the eye stops seeing fluorescence.
- Reporting a titer without a pattern, which discards the half of the result that discriminates Cheng 2021.
Reference interval or decision threshold — which kind of number ANA (Antinuclear Antibodies) is
There is no reference interval. There is a screening cut-off, and it was chosen by the laboratory. Positivity at 1:40 is common in healthy people; positivity at 1:160 is less so; positivity at 1:640 with a defined pattern is uncommon. The cut-off is a trade between sensitivity and the number of well people who will be investigated Volkmann 2012.
The test's real strength is its negative predictive value. A negative ANA by immunofluorescence makes systemic lupus erythematosus very unlikely. Its positive predictive value in an unselected person with fatigue is poor, and that asymmetry is the single most important thing to know before ordering it Pisetsky 2017.
Anti-DFS70 is the one result that actively argues against disease. A systematic review and meta-analysis found anti-DFS70 antibodies useful for differentiating systemic autoimmune rheumatic disease from non-disease in patients with a positive ANA Cheng 2021, and their prevalence in healthy individuals compared with ANA-associated disease has been measured directly Hayashi 2021.
What follows a positive result is where the harm lives. Education and clinical decision support were shown to improve the quality of positive ANA referrals Patel 2021, which is another way of saying that a large share of them should not have been made.
How you would know your ANA (Antinuclear Antibodies) was wrong — and when to redraw
Do not repeat a positive ANA to see whether it has changed. Titer does not track disease activity in lupus and has no established monitoring role; it is a qualifying test, not a follow-up one Pisetsky 2017.
If a repeat is genuinely needed, allow at least 6 months, and only if the clinical picture has changed. Antibody populations shift on the timescale of B-cell clonal dynamics, not weeks.
Conditions that must match: the same method and the same laboratory Sanchez-Hernandez 2023; the same starting dilution; and no intercurrent infection or newly started drug.
What would have to change for the second result to mean something:
- ANA positive at a low titer with a dense fine speckled pattern? The next test is a specific anti-DFS70 assay, which can point away from rheumatic disease rather than toward it Cheng 2021 Sanchez-Hernandez 2023.
- ANA positive with symptoms? The informative tests are the specific antibodies — anti-dsDNA, anti-Sm, anti-Ro, anti-La, anti-centromere, anti-Scl-70 — not a repeat titer Volkmann 2012.
- ANA positive and you feel fine? Prevalence in healthy people is high enough that this is the expected finding, not a prediction Pashnina 2021 Krzemien 2022.
- Fatigue driving the whole investigation? A CBC, ferritin, TSH and hs-CRP account for far more fatigue in an unselected adult than autoimmunity does.
What ANA (Antinuclear Antibodies) cannot tell you
It cannot diagnose anything on its own. Every classification criterion that uses ANA requires clinical features alongside it.
It cannot be used to monitor disease. The titer does not track activity Pisetsky 2017.
It cannot distinguish a healthy person with autoantibodies from an early patient, and most positives in a healthy population stay healthy Pashnina 2021 Krzemien 2022.
A negative solid-phase screen does not exclude what a negative immunofluorescence screen excludes, because the antigen panels differ Pisetsky 2017.
The wrong inference readers actually draw is that a positive ANA means an autoimmune disease is present or coming. In a person with no symptoms it usually means neither — positivity is common with age, the pattern often points away from disease, and the documented harm of the test in this setting is the cascade of referrals it starts Patel 2021 Volkmann 2012.
Sources read for these sections
- Pashnina IA, et al. Antinuclear Autoantibodies in Health: Autoimmunity Is Not a Synonym of Autoimmune Disease. Antibodies (Basel) 2021 · PMID 33668697
- Krzemien P, et al. Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population. Rheumatology International 2022 · PMID 34755204
- Hayashi N, et al. Prevalence of anti-dense fine speckled 70 antibodies in healthy individuals and patients with antinuclear antibody-associated autoimmune rheumatic diseases in Japan. Medicine (Baltimore) 2021 · PMID 33655922
- Cheng CF, et al. Anti-DFS70 Antibodies for Differentiating Systemic Autoimmune Rheumatic Disease in Patients with Positive ANA Tests: A Systematic Review and Meta-Analysis. Diagnostics (Basel) 2021 · PMID 34573934
- Sanchez-Hernandez ES, et al. The Nuclear Dense Fine Speckled (DFS) Immunofluorescence Pattern: Not All Roads Lead to DFS70/LEDGFp75. Diagnostics (Basel) 2023 · PMID 36673033
- Volkmann ER, et al. Using the antinuclear antibody test to diagnose rheumatic diseases: when does a positive test warrant further investigation?. Southern Medical Journal 2012 · PMID 22267099
- Patel V, et al. The impact of education and clinical decision support on the quality of positive antinuclear antibody referrals. Clinical Rheumatology 2021 · PMID 33474658
- Pisetsky DS. Antinuclear antibody testing - misunderstood or misbegotten?. Nature Reviews Rheumatology 2017 · PMID 28541299
Where to start with ANA (Antinuclear Antibodies)
In this order. Start at the supplement and you learn nothing, because you never established the number was real.
You have the range, where it came from and the first two moves. Inside is the rest of the five-pathway protocol — supplements, hormones, peptides — the order to run them in, and what to change when the number will not move.
Get the full protocol — $10/mo →📚 American College of Rheumatology guidance on ANA testing and interpretation.
🩸 Test your ANA (Antinuclear Antibodies)
Order directly through Marek Diagnostics — no doctor's visit needed, drawn at any Quest location in the US. Code CAMERON applies 10% off automatically.
Order this test — 10% off → Browse all 103 markers →What ANA (Antinuclear Antibodies) is usually tested alongside
One marker is a data point. These panels add the markers that make ANA (Antinuclear Antibodies) interpretable, name why each is on the list, and load the set into your cart at 10% off.
includes this + 8 more markers — Joint pain, unexplained rashes, recurring low-grade fevers, profound fatigue, or a family history of autoimmune disease.
What people use ANA (Antinuclear Antibodies) to decide
Nobody orders a test for its own sake. ANA (Antinuclear Antibodies) is on the test list for these pathways — each one links to what the pathway claims, and what its test list is read for before you spend anything on it.
Distinguishes normal healing inflammation from a chronic smolder that never resolves. Persistently high CRP months after an injury is a resolution failure, and it responds to completely different things than acute inflammation does.
Fog with no attention deficit and no mood change is often immune rather than neurotransmitter. Raised inflammatory markers point at this pathway; a clean panel argues you should be looking somewhere else on this page.
Give someone interferon and a meaningful fraction become clinically depressed — the causal link is not in doubt. If CRP is raised and mood is low, this pathway comes first.
Distinguishes wear-and-tear from inflammatory arthritis, and that distinction changes everything about what to do next. Morning stiffness lasting over an hour with raised markers is not osteoarthritis.
ANA (Antinuclear Antibodies) is also on the test list for these, where it narrows the picture rather than settling it:
Would you feel it? Symptoms ANA (Antinuclear Antibodies) helps explain
People search for how they feel, not for a marker. These are the complaints where this one is worth checking, and whether it is first-line or a follow-up.
Why your ANA (Antinuclear Antibodies) might be wrong
Most abnormal results are interference, not disease. Check these before you change anything. Each says whether the number is wrong (repeat it), badly timed (redraw it), or real with a cause.
ANA by immunofluorescence and by ELISA are not the same test and do not agree with each other. Titre and pattern come only from IFA.
Ask which method was used. A bare 'positive' without a titre and pattern is not a result.
10–15% of entirely healthy people are ANA positive, rising with age — toward a quarter of women over 60. This is not really interference, it is base rate, and it is the most misread result in medicine.
A positive ANA with no symptoms usually means nothing. Do not chase it.
Hydralazine, procainamide, minocycline, some anti-TNF biologics and others can induce a positive ANA.
Review your medication list before any autoimmune workup.
What ANA (Antinuclear Antibodies) means in combination
One marker tells you a little; combinations tell you the story. These are the named patterns this one takes part in.
10–15% of entirely healthy people are ANA positive, rising toward a quarter in women over 60, while lupus affects well under 0.1%. In a well person a positive ANA is far more likely to be a false alarm than a disease, and the anxiety it generates is a real harm.
Do not chase it. Do not repeat it — ANA titres do not track disease activity. It becomes meaningful only alongside symptoms and raised inflammatory markers.
The combination that actually means something. The antibody alone is weak evidence; the antibody plus a clinical picture plus objective inflammation is a referral. Unexplained low white cells, platelets or hemoglobin carry more weight here than the titre does.
Rheumatology. If rheumatoid arthritis is the question, add anti-CCP — far more specific than rheumatoid factor and positive years before symptoms.
What a proper workup looks like
This one’s retest schedule belongs with a clinician, not a calendar — so the useful thing to know is what a good assessment looks like, enough to tell whether you got one.
The titre and the pattern, not just "positive". A bare positive is close to useless — 1:40 and 1:1280 are both positive and mean entirely different things, and the staining pattern (homogeneous, speckled, nucleolar, centromere) points at different conditions. If your report only says positive, the number exists; ask for it. If the titre is meaningful and you have symptoms, the follow-on panel is ENA (anti-Ro, anti-La, anti-Sm, RNP, Scl-70), anti-dsDNA, and complement C3 and C4, alongside ESR and CRP.
Real autoimmune disease usually shows a higher titre, plus a specific antibody, plus something objective — raised inflammatory markers, low complement, or a finding a clinician can see. A positive ANA with a normal CRP, normal complement, negative ENA and no physical findings is, most of the time, just a positive ANA.
This is the marker where the harm usually comes from doing too much. A low-titre positive in a well person leads to repeat testing, private panels, elimination diets and years of low-grade worry about a disease nobody has. Up to about 15% of healthy people are positive at low titres. Repeating an ANA that was positive does not add information — the antibody does not track disease activity, which is exactly why the retest advice defers to a specialist instead of giving you an interval. If you have symptoms and were dismissed, the useful ask is the ENA and complements, not another ANA.
“Given my titre, pattern and normal inflammatory markers — is there anything to act on here, or is this an incidental positive?”
What to test next
These put ANA (Antinuclear Antibodies) in context — each with its own full breakdown.
Frequently asked questions
Negative, or a titer such as 1:40, 1:80, 1:160 with a pattern. Ranges vary by laboratory and assay — always compare to the range printed on your own report.
Negative. The Art of Interpreting Antinuclear Antibodies in Everyday Practice, Journal of Clinical Medicine, 2025; 2019 EULAR/ACR SLE classification criteria.
Interpret only alongside symptoms. A positive ANA with joint pain, rash, dry eyes/mouth or unexplained inflammation warrants rheumatology referral. A positive ANA with no symptoms usually needs nothing.
Negative is reassuring when autoimmune disease is suspected.
You can order ANA (Antinuclear Antibodies) directly through Marek Diagnostics without a doctor's visit — drawn at any Quest Diagnostics location in the US. Code CAMERON applies 10% off automatically.
Where this goes next
This page is the free framework. The protocol itself — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.